The way the brain develops can shape us throughout our lives, so neuroscientists are intensely curious about how it happens.
Dr. Ian Flinn explains in an interview with CURE how Lunsumio VELO (mosunetuzumab) works and its impact on patients with ...
Researchers from Kyushu University discovered a previously unrecognized synaptic "hotspot" that forms during adolescence, ...
ANKTIVA® plus checkpoint inhibitor (CPI) therapy demonstrated statistically significant immune restoration across two ...
American Skin Association (ASA) is pleased to announce that Steven A. Rosenberg, MD, PhD, a pioneering figure in cancer immunotherapy, was appointed as the newest member of its distinguished Board of ...
A major achievement with far-reaching implications for treating deadly skin cancer has been discovered by Tel Aviv University ...
Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines ...
7d
World-renowned Immunologist and Distinguished Scientist Joins CancerVax as Senior Scientific Advisor
Lehi Utah, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Lehi, Utah, January 7, 2026 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to ...
Metabolic diseases, including but not limited to diabetes mellitus, metabolic-associated fatty liver disease, hyperlipidemia, hyperuricemia, and gout, are ...
Shimon Sakaguchi is the scientific founder and a director of RegCell, a Japanese start-up working on treatments based on regulatory T-cells. He is also a scientific advisor for biotechnology company ...
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced new paradigm changing findings from the Phase 2 QUILT-3.055 study, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback